Recent studies have shown that IVM can exert anti-tumor effects through multiple pathways, such as inhibiting the WNT-TCF signaling pathway, modulating PAK1, and inducing mitochondrial dysfunction [6,22,23]. The gene discussed is PAK1; the disease is neoplasm.